Clinical Report: Frequency and Determinants of Hepatitis C Virus Infection in Psychiatric Inpatients in Poland

Overview

A cross-sectional survey in Polish psychiatric wards revealed a 1.3% prevalence of active hepatitis C virus (HCV) infection among hospitalized patients. Key risk factors identified include intravenous drug use, liver disease, and previous incarceration.

Background

Hepatitis C virus (HCV) poses a significant public health risk, particularly among vulnerable populations such as psychiatric patients. These individuals often engage in high-risk behaviors that increase their susceptibility to HCV infection. The lack of routine screening in psychiatric settings contributes to the underdiagnosis of HCV, necessitating targeted interventions.

Data Highlights

Key Findings

• 1.3% prevalence of active HCV infection among psychiatric inpatients.
• Five significant risk factors for HCV infection identified: intravenous drug use, liver disease, blood transfusions prior to 1992, substance abuse disorders, and previous incarceration.
• Intravenous drug use had the highest odds ratio (OR = 9.40).
• Routine HCV screening is lacking in psychiatric settings, contributing to underdiagnosis.
• Early detection and treatment of HCV can prevent severe liver disease and reduce overall disease burden.

Clinical Implications

The findings highlight the need for routine HCV screening in psychiatric wards to identify and treat infections early. Addressing the high prevalence of HCV in this population can significantly impact public health outcomes.

Conclusion

The study underscores the importance of targeted HCV screening in psychiatric settings to mitigate the risks associated with this infection in vulnerable populations.

Related Resources & Content

1. Open Forum Infectious Diseases, 2023 -- Seroprevalence of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Among People Who Use Drugs in Turkey
2. Infection, 2022 -- Absence of Association Between Hepatitis E Virus Infection Rates and Schizophrenia Diagnosis
3. BMJ Mental Health, 2023 -- Factors associated with infection-related hospitalisations in severe mental illness: a retrospective cohort study
4. WHO, 2026 -- Hepatitis C Fact Sheet
5. ECDC, 2025 -- Testing of HIV, hepatitis B and hepatitis C in the European Union/ European Economic Area (EU/EEA)
6. Infection — Infection Control: A Comparative Analysis of Point Prevalence and Incidence Studies in Long-Term Care Facilities in the Małopolska Region of Poland (2009–2010)
7. AASLD–IDSA HCV Guidance
8. Program Moje Zdrowie | Pacjent
9. Hepatitis C
10. Testing of HIV, hepatitis B and hepatitis C in the European Union/ European Economic Area (EU/EEA)
11. Recommendation of the President regarding #PPZ #48aa – Prevention of chronic HCV and HBV infections - Agency for Health Technology Assessment and Tariff System
12. Frontiers | Prevalence and predictors of HCV infection among hospitalised psychiatric patients in Poland
13. Retrospective study of hepatitis C screening and seroprevalence in the GHU Paris - ScienceDirect